Stock Trend Analysis Report
Prepared for you on Monday, March 1, 2021.
Adaptimmune Therapeutics Plc ADS (NASDAQ:ADAP)
Crossroads (-60) - ADAP is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid ADAP?
MarketClub looks at technical strength and momentum to determine if the timing is right for ADAP.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for ADAP
The long-term trend has been UP since Feb 8th, 2021 at 6.415
The intermediate-term trend has been DOWN since Feb 23rd, 2021 at 5.460
The short-term trend has been DOWN since Feb 12th, 2021 at 6.530
Smart Scan Analysis for ADAP
Based on our trend formula, ADAP is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||14.625||Year High Date||2018-05-10|
|Year Low||4.91||Year Low Date||2018-11-28|
|52wk High||13.4||52wk High Date||2020-06-01|
|52wk Low||2||52wk Low Date||2020-03-16|
|Average Volume||1,084,989||Market Cap||158M|